As part of our commitment to be a leader in women’s health care, we continually conduct clinical research studies to advance treatment methods and to identify the most effective means to care for patients.We want to be on the cutting edge of medicine and contribute, first-hand, to benefit not only Rosemark patients but also patients around the world.
Rosemark Clinical Research is now enrolling participants in investigational drug studies in the following areas:
This study will assess the potential impact of Elagolix on disordered pituitary and ovarian hormones in women with Polycystic Ovary Syndrome (PCOS).
The purpose of this study is to assess the safety and efficacy of MT-
2990 for treatment of moderate to severe endometriosis-related pain in women with
surgically diagnosed endometriosis.
The primary objective of this study is to demonstrate the superior efficacy versus placebo of OBE2109 alone and in combination with add-back therapy for the reduction of heavy menstrual bleeding associated with uterine fibroids in premenopausal women.